Vivos (RDGL) Long-Term Investments (2010)
Vivos (RDGL) posted Long-Term Investments of $10000.0 for Q4 2010.
Vivos (RDGL) Long-Term Investments (2010) Analysis & Trends
Vivos has reported Long-Term Investments for 1 years, with the latest figure at $10000.0 in Q4 2010.
- Quarterly Long-Term Investments changed N/A year-over-year to $10000.0 in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $10000.0 (changed N/A YoY) and the FY2010 annual result came in at $10000.0, changed N/A from the prior year.
- Long-Term Investments was little changed at $10000.0 in Q4 2010 per RDGL's latest filing.
- Over five years, Long-Term Investments peaked at $10000.0 in Q4 2010 and troughed at $10000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 10,000.00 |